Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction

被引:19
作者
Hudzik, Bartosz [1 ,2 ]
Korzonek-Szlacheta, Ilona [2 ]
Szkodzinski, Janusz [1 ]
Liszka, Radosaw [1 ]
Lekston, Andrzej [1 ]
Zubelewicz-Szkodzinska, Barbara [2 ]
Gasior, Mariusz [1 ]
机构
[1] Med Univ Silesia, Div Dent Zabrze, Sch Med, Dept Cardiol 3,Silesian Ctr Heart Dis, Katowice, Poland
[2] Med Univ Silesia, Sch Publ Hlth Bytom, Dept Nutr Related Dis Prevent, Katowice, Poland
关键词
Multimorbidity; Diabetes mellitus; Myocardial infarction; Mean platelet volume; C-REACTIVE PROTEIN; MULTIPLE CHRONIC CONDITIONS; MICROVASCULAR COMPLICATIONS; INFLAMMATORY MARKERS; PREDICTIVE VALUES; LYMPHOCYTE RATIO; GLYCEMIC CONTROL; RISK; MELLITUS; BURDEN;
D O I
10.1007/s00592-017-1079-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) is one of the most frequently detected conditions in multimorbid disease clusters. Platelet activation is one of the key mechanisms underlying atherothrombosis in acute myocardial infarction. Available data link mean platelet volume (MPV) to poor prognosis not only in cardiovascular and non-cardiovascular disease. Given the lack of research data on the association between disease clusters and MPV, we have set out to investigate the link between multimorbidity and MPV in diabetic patients with acute myocardial infarction. A total of 277 patients with DM and STEMI undergoing primary percutaneous coronary intervention were enrolled. Based on the number of comorbidities the study population was divided into two groups: group 1 (N = 58) with <= 1 comorbidity and group 2 (N = 219) with >= 2 comorbidities. A subanalysis was performed within the multimorbidity group: group 2A with two or three comorbidities (N = 156) and group 2B with at least four comorbidities (N = 63). In the study population, 15.9% of patients had one comorbidity, and 22.0, 34.3, and 22.7% of patients had two, three, or at least four comorbid conditions, respectively. Both MPV and PDW were elevated in multimorbid patients (9.3 vs 10.8 fl and 9.5 vs 10.3 fl, respectively). The highest platelet volume indices were observed in patients with at least four comorbid conditions. There was a moderate positive correlation between MPV and the total number of comorbidities, the number of CVD comorbidities, and the number of non-CVD comorbidities. These findings indicate that multimorbidity is associated with an increase in platelet volume indices. MPV values increased with the increasing number of comorbid conditions. Importantly, MPV values were elevated in some, but not all CVD and non-CVD conditions.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 62 条
  • [1] The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation
    Agapakis, Dimitris I.
    Massa, Eleni V.
    Hantzis, Ioannis
    Maraslis, Stefanos
    Alexiou, Evagelos
    Imprialos, Konstantinos P.
    Damianidou, Maria
    Satsoglou, Emilios
    [J]. RESPIRATORY CARE, 2016, 61 (01) : 44 - 49
  • [2] The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country
    Alonso-Moran, Edurne
    Orueta, Juan F.
    Fraile Esteban, Jose Ignacio
    Arteagoitia Axpe, Jose M.
    Luz Marques Gonzalez, M.
    Toro Polanco, Nuria
    Ezkurra Loiola, Patxi
    Gaztambide, Sonia
    Nuno-Solinis, Roberto
    [J]. BMC PUBLIC HEALTH, 2014, 14
  • [3] Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study : Reply to Dr. Tasci et al.
    Anjana, R. M.
    Amutha, A.
    Mohan, V.
    [J]. ACTA DIABETOLOGICA, 2016, 53 (01) : 131 - 132
  • [4] [Anonymous], 2013, CLIN EPIDEMIOL, DOI [DOI 10.2147/CLEP.S49485, 10.2147/CLEP.S49485]
  • [5] [Anonymous], 2002, Innovative Care for Chronic Conditions: Building Blocks for Action
  • [6] Arikanoglu A, 2013, EUR REV MED PHARMACO, V17, P1774
  • [7] Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension
    Bautista, LE
    Vera, LM
    Arenas, IA
    Gamarra, G
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2005, 19 (02) : 149 - 154
  • [8] C-reactive protein and other inflammatory risk markers in acute coronary syndromes
    Blake, GJ
    Ridker, PM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) : 37S - 42S
  • [9] Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis
    Brown, AS
    Hong, Y
    deBelder, A
    Beacon, H
    Beeso, J
    Sherwood, R
    Edmonds, M
    Martin, JF
    Erusalimsky, JD
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (04) : 802 - 807
  • [10] The mean platelet volume in subjects with impaired fasting glucose
    Coban, E
    Bostan, F
    Ozdogan, M
    [J]. PLATELETS, 2006, 17 (01) : 67 - 69